FDA Accepts Supplemental New Drug Application for Tapinarof Cream, 1%, in Atopic Dermatitis
April 29th 2024The acceptance is based on positive data from the phase 3 ADORING 1 and ADORING 2 pivotal trials, as well as interim results from the phase 3 ADORING 3 open-label, long-term extension trial.
Read More
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood Cancer
Advances, challenges, and promising innovations emerge.
Read More
Public Health Matters: Entrepreneurship, MedsPLUS Consulting, and Reaching Marginalized Communities
April 25th 2024Tune into this episode of “Public Health Matters” to learn about Dr. Pauline K. Long and her entrepreneurship journey, as well as how she creates meaningful impacts on patients in marginalized communities and within public health.
Listen
FDA Approves Pivmecillinam for Treatment of Female Adults With Urinary Tract Infections
April 24th 2024Pivmecillinam (Pivya; UTILITY therapeutics Ltd) tablets were approved for female adults with uncomplicated urinary tract infection caused by Escherichia coli, Proteus mirabilis, and Staphylococcus saprophyticus.
Read More